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Abstract
In idiopathic pulmonary arterial hypertension (PAH), increased pulmonary
vascular resistance is associated with structural narrowing of small (resistance)
vessels and increased vascular tone. Current information on pulmonary vascu-
lar remodeling is mostly limited to averaged increases in wall thickness, but
information on number of vessels affected and internal diameter decreases for
vessels of different sizes is limited. Our aim was to quantify numbers of
affected vessels and their internal diameter decrease for differently sized vessels
in PAH in comparison with non-PAH patients. Internal and external diame-
ters of transversally cut vessels were measured in five control subjects and six
PAH patients. Resistance vessels were classified in Strahler orders, internal
diameters 13 lm (order 1) to 500 lm (order 8). The number fraction, that is,
percentage of affected vessels, and the internal diameter fraction, that is, per-
centage diameter of normal diameter, were calculated. In PAH, not all resis-
tance vessels are affected. The number fraction is about 30%, that is, 70% of
vessels have diameters not different from vessels of control subjects. Within
each order, the decrease in diameter of affected vessels is variable with an
averaged diameter fraction of 50–70%. Narrowing of resistance vessels is
heterogeneous: not all vessels are narrowed, and the decrease in internal diam-
eters, even within a single order, vary largely. This heterogeneous narrowing
alone cannot explain the large resistance increase in PAH. We suggest that
rarefaction could be an important contributor to the hemodynamic changes.
Introduction
Idiopathic pulmonary arterial hypertension (iPAH) is
generally assumed to result from decreased internal diam-
eters of the small vessels, often labeled as resistance
vessels. Resistance may increase up to a factor ~4–5 and
consequently mean pulmonary artery pressure may
increase by a similar amount (Chazova et al. 1995; Lan-
khaar et al. 2008, 2006; Overbeek et al. 2008; Palevsky
et al. 1989; Peacock et al. 2011; Stacher et al. 2012).
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Internal diameters of these resistance vessels can be
reduced by vasoconstriction or (concentric) remodeling,
and because in only a minority of PAH patients acute
vasodilator challenges result in a substantial pressure
decrease, concentric remodeling is considered to be the
major factor in vessel narrowing and augmentation of
pulmonary vascular resistance (Palevsky et al. 1989). Inhi-
bition of vascular remodeling is considered as an effective
therapeutic target.
However, quantitative information on remodeling of
resistance vessels from iPAH patients, in comparison with
non-PAH, is almost exclusively limited to the increase in
relative wall thickness, expressed as WT = (do–di)/
do 9 100%, with do and di external and internal diame-
ter. In general, wall thickness is most often presented in
terms of average values, not discriminating between vessel
size (Palevsky et al. 1989; Stacher et al. 2012). Chazova
et al. (1995) reported on averaged wall thickening in six
diameter groups of arteries, and showed that the wall
thickness increase in iPAH, and therefore the internal
diameter change, may depend on vessel size. In the same
study, wall thickening of the pulmonary veins is also
reported. Anderson et al. (1973) reported similar findings
in three PAH patients. However, only averaged data were
reported, while the percentage of vessels affected and the
possible variation in degree of vessels narrowing were
not. Hence, to the best of our knowledge, in the pub-
lished literature on PAH, very little quantitative informa-
tion has been provided pertaining to the number of
affected vessels and the degree of internal diameter
decreases of differently sized vessels in the (peripheral)
pulmonary vascular bed. Quantitative information on
internal diameters is required to accurately estimate vas-
cular resistance.
Therefore, we determined internal and external diame-
ters of pulmonary resistance vessels (13 to 500 lm; Strah-
ler orders 1–8) and number of occluded vessels in
histological slides of healthy subjects and PAH patients,
and quantified the fraction of narrowed vessels and their
degree of narrowing in each Strahler order (Horsfield
1978; Huang et al. 1996, 2011).
Methods
Internal and external diameters
Lung tissue was obtained from the biobank at the depart-
ment of pathology of the VU University Medical Center,
Amsterdam, the Netherlands. The study was approved by
the Institutional Review Board on Research Involving
Human Subjects of the VU University Medical Center.
Tissue of control subjects was obtained from people who
died acutely due to traumatic causes (mean age: 40.8
(24–79) years; 100% male). Tissues were analyzed from
five idiopathic PAH and one hereditary PAH patient (#2),
all of whom were diagnosed following prevailing diagnos-
tic criteria (three males, all normal BMI, four nonsmok-
ers). Diagnosis was confirmed at autopsy by histological
observation of vascular remodeling and plexiform lesions
(Fig. 1). Mean age was 54 (45–57) years at death. The
patient cases were part of an earlier study (Overbeek et al.
2009). Lung parenchyma was perfused with and fixed in
formalin and tissue from different lobes was embedded in
paraffin. Serial sections of 4 lm thickness were subjected
to conventional hematoxylin and eosin staining to con-
firm diagnosis and Elastica van Gieson staining for evalu-
ation of structural changes. Per subject, the external and
internal diameter of all transversally cut vessels (arterial
and venous, grouped) encountered in one tissue block
with average size of 2.75 cm2  0.26 cm2 between 13 and
500 lm were measured, by determining the mean dis-
tance between the lamina elastica externa and lumen in
two perpendicular directions (see Fig. 1A). Number of
vessels counted in each Strahler order is reported in the
Table S1.
By comparing PAH internal diameters with their nor-
mal values found in the controls, the number of nar-
rowed PAH vessels and their degree of narrowing were
determined. This was done per order for Strahler orders
m = 1 to m = 8, that is, resistance vessels with diameters
of 13 lm to 500 lm (Table S1).(Huang et al. 1996, 2011)
We introduced for each order m, a number fraction
Fn(m), which is the fraction of narrowed vessels with
respect to the total number of vessels, and a diameter
fraction Fd(m), which is the internal diameter as a frac-
tion of the normal internal diameter. The diameter frac-
tion Fd(m) of a narrowed vessel thus expresses the
percentage that is left of a narrowed vessel. On both
number and diameter fraction, linear regression analysis
was performed.
Determinations of number fraction and
diameter fraction
To determine Fn(m) and Fd(m), firstly, the internal diam-
eters di were plotted as a function of the external diame-
ters do. Subsequently, linear regression analysis was
performed on the logarithmic diameter values of all con-
trol data to get a control relation between internal and
external diameter for normal vessels. Furthermore, the
iPAH data were categorized in orders based on external
diameter, as follows: the categorization criteria were
obtained from Horsfield, who labeled vessels based on
internal diameter (Horsfield 1978; Huang et al. 1996).
These internal diameters were converted to external diam-
eters using our control relation.
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Next, a one-sided 90% prediction interval for the con-
trol relation, called the prediction line, was determined to
define normal and narrowed vessels in iPAH. Narrowed
vessels were the iPAH vessels lying below this prediction
line. In every order m, the number of narrowed vessels
was counted and divided by the total number of vessels,
to calculate the number fraction Fn(m). Linear regression
analysis was performed on Fn(m) to construct a regres-
sion line of Fn(m) as a function of order m with a 95%
confidence interval.
To calculate one value of the diameter fractions Fd(m)
for each order m, first, the normal internal diameters of
each narrowed vessel were obtained from the control
relation. Second, their measured internal diameter was
divided by their calculated normal internal diameter to
calculate the diameter fraction of each narrowed vessel,
and these were plotted per order. Next, linear regression
analysis was performed on the diameter fractions to
construct a regression line of the diameter fraction
Fd(m) as a function of order m with a 95% confidence
interval.
Occluded vessels
Immunofluorescent staining with von Willebrand factor
antibody conjugated to FITC (vWf, 1:200 dilution, over-
night incubation at 4°C, Abcam, Ab8822) combined with
a-smooth muscle actin conjugated to Cy3 (a-SMA, 1:200
dilution, 2 h at room temperature, Sigma, C6198) was
performed on control and PAH lung tissue to determine
the number of occluded vessels as percentage of the total
number of vessels. Approximately, 30–68 vessels below
100 lm were studied in 7–12 fields of view per subject.
Occlusion was defined by vWf staining completely com-
prising the luminal surface of a vessel. Imaging was per-
formed at 109 magnification with an Axiovert 200
Marianas inverted wide-field fluorescence microscope
(Carl Zeiss Microscopy, Jena, Germany). These
200 µm50 µm
100 µm200 µm
A B
C D
Figure 1. Wall thickness measurement and vascular remodeling seen in PAH. (A) Example of determining the wall thickness of a pulmonary
vessel by measuring the lamina elastica externa and lumen in two perpendicular directions in all transversally cut vessels between 13 and
500 lm encountered per slide. Examples of typical vascular remodeling observed in the lung tissue of pulmonary arterial hypertension patients
in our study group, like intimal fibrosis (B; H&E staining) and medial thickening (C; Elastica van Gieson staining) in a pulmonary artery and a
plexiform lesion (D; H&E staining). Scalebar indicates 100 lm.
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percentages were averaged for controls and patients and
given as mean  SEM.
Results
Patient characteristics, including hemodynamic profiles,
of the PAH patients are, when known, shown in Table 1.
Internal and external diameters
Heterogeneous vascular remodeling was seen in PAH
patients, with varying thickening of the intimal and med-
ial vascular layers. PAH patients showed intimal fibrosis
and medial thickening but no significant increase in com-
plete vascular occlusions; 10.4  2.3% of the vessels of
PAH patients were occluded, compared to 6.6  3.5% in
control subjects (Fig. 2).
Figures 3, 4 show the relations between internal and
external diameters of the control subjects and PAH
patients, respectively, with their linear fits. The control
data showed a clear linear relation (R2 between 0.984 and
0.996). The mean relative wall thickness (WT) of all con-
trol vessels was about 16% (mean  95% CI:
16.3%  0.7%). Patient data showed a weaker relation
between internal and external diameter (R2 between 0.668
and 0.985) and a mean WT of all vessels of about 22%
(22.0%  1.2%). However, many PAH data points
appeared to follow the control regression line indicating
unaffected vessels.
Figure 5 shows the diameter relations on a log–log
scale. Diagram A shows the data of all controls with the
control regression line and the lower 90% control
prediction line. Panel B shows the data of all PAH
patients with the control regression line and lower 90%
control prediction line. About 70% of the PAH data
points are above this prediction line and are considered
as vessels with a nonreduced internal diameter, while 30%
(in gray) are below the prediction line and thus have a
significantly reduced inner diameter. The normal vessels
had a mean WT of 14%  0.6%, and the narrowed ves-
sels had a mean WT of 39%  2%.
The number fractions Fn(m) (diagram A) and the
diameter fractions (diagram B) of the PAH vessels are
shown by order in Figure 6. The linear regression lines of
the data with the 95% CIs are shown.
Discussion
We determined external and internal diameters of pul-
monary vessels in the range of 13–500 lm, Strahler
orders 1–8. The internal and external diameters of the
control vessels were all located in a narrow range
around the regression line (Fig. 5A), while in the PAH
patients, on average, about 30% of the vessels were nar-
rowed (Fig. 6A, number fraction), thus ~70% was in
the range of the control subjects. This was the first
heterogeneity observed: not all vessels are narrowed. A
second heterogeneity was that in each Strahler order,
the affected vessels showed a large range of variation in
internal diameter.
Diameter and wall thickness
We here report data on internal and external diameters of
the pulmonary vasculature, and thus were able to derive
relative wall thickness from the slope of the relation
between internal and external diameters (Fig. 3, 4) as
WT = 1-slope. Only wall thickness (intima plus media)
was studied, changes in wall composition (e.g., isolated
media hypertrophy etc.) were not determined. To the best
of our knowledge, number and diameter fractions, pre-
sented in Figure 6, implying heterogeneous narrowing,
are unique and a direct comparison with the literature is
not possible.
In control subjects, we find an average slope of 0.83,
thus an average wall thickness of ~17%, which is close to
wall thickness reported by Chazova (~18%) (Chazova
et al. 1995). (Stacher et al. 2012) however, recently
reported considerably thicker vessel walls in controls
(about 30%). Of all vessels studied, 8.3% was occluded.
Because vWF stains both, endothelial cells and platelets,
our histological analysis does not allow for a discrimina-
tion between occlusion due to thrombotic material and
occlusion due to endothelial hyperproliferation.
Table 1. General patient characteristics.
Male/female, no 3/3
Age at death (years) 54 (45–57)
mPAP (mmHg) 59 (44–76)
PAWP (mmHg) 6 (0–11)
PVR (dynscm-5) 856.6 (455–1587)
CO (L/min) 4.8 (3.6–5.8)
CI (L/min/m2) 2.6 (1.9–3.5)
Smoking history (never/current/former, n) 4/0/2
Therapy
Prostacyclin 5
ERA 1
PDE-5 inhibitor 1
ABS 2
ABS, atrial balloon septostomy; CI, cardiac index; CO, cardiac out-
put; ERA, endothelin receptor antagonist; mPAP, mean pulmonary
artery pressure; PAWP, pulmonary artery wedge pressure; PDE-5,
phosphodiesterase 5; PVR, pulmonary vascular resistance.
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In PAH, we found the number of occluded vessels to be
similar to control. Diameter relations vary greatly, but
their average slope (Fig. 4) (when all vessels are included)
is 0.66, resulting in an averaged wall thickness of 34%.
Calculation of averaged wall thickness including the
occluded vessels would only minimally increase the calcu-
lated average wall thickness, to about 39%. Chazova et al.
(1995) report, at systolic/diastolic PAP 120/60 mmHg,
thus estimated mPAP ~70 mmHg, a wall thickness of 50%
for vessels with diameters between 25 and 250 lm. Stacher
et al. (2012) report wall thickness in hypertension at a
mPAP ~58 mmHg about 60%. However, it is not entirely
clear if all vessels are included in the Chazova et al. (1995)
and Stacher et al. (2012) studies. Palevsky et al. (1989) use
wall area, with WA = 100 9 wall area/total vessel cross-
sectional area and found 64%, and thus wall thickness
equaling √(1-fractional WA) is about 60% with range 40–
75%, at a mPAP of ~60 mmHg.
Can vascular changes predict pulmonary
vascular resistance?
Calculation of PVR, to estimate the contribution of vas-
cular remodeling to resistance increase, requires the deter-
mination of the total number and internal diameters of
all vessels in the entire lung. These data are not available.
However, a relative increase in PVR from control to PAH
can be obtained as follows. We found a number fraction
of 30% (Fig. 6A), that is, 70% of normal vessels remain.
When we assume that, in controls and PAH patients, the
percentage of occluded vessels are similar, that length
changes do not occur and that all narrowed vessels are
completely closed (i.e., thus not contributing to flow; this
leads to an overestimation of the actual resistance), 30%
of abnormal vessels would result in an 1/0.7 = 1.4-fold
increase in PVR in PAH. Maximal PVR in healthy indi-
viduals, within the limits of normal is 99 dynescm-
100 µm 
CONTROL PAH
A B
C D
*
*
*
E F
Figure 2. Vascular occlusions assessed with immunofluorescent staining. Besides thickening of the intimal (B, asterix) and medial (D,
arrowhead) vascular layer in pulmonary arterial hypertension compared with control (A, asterisks; C, arrowhead), a great number of vessels is
not occluded (A and D, arrows) when assessed with immunofluorescent von Willebrand factor staining. Vascular remodeling does not occur in
all vessels in PAH tissue (E) and still look similar to control vessels (F). Scale bar indicates 100 lm.
ª 2017 The Authors. Physiological Reports published by Wiley Periodicals, Inc. on behalf of
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5.(Peacock et al. 2011) Thus, the value of 1.499 = 138.6
dynescm-5, is far lower than the resistance in our patient
group, which is 857 dynes cm-5 (Table 1). This can partly
be explained by the vascular reservoir capacity and blood
flow recruitment the lung has, strengthened by the find-
ing of Burrowes et al. (2011) who calculated that more
than 50% of the vessels have to be obstructed to increase
PVR.
The number of occluded vessels we found and the
small number of affected vessels between control and
PAH, is considerably smaller than the 65% of mechani-
cal obstruction that Burrowes et al. (2011) calculated to
be required to increase the mPAP above 25 mmHg.
The relatively large number of vessels with the same
diameter as control vessels, if still functional, would suggest
considerable effect of vasodilation. Since this is not the
case, the vessels with normal wall thickness are either not
functioning normally or pulmonary resistance is greatly
affected by rarefaction or (changed) venous resistance.
Rarefaction has been debated (Mooi and Wagenvoort
1983). In animal experiments, the resistance of the venous
system has been shown to be considerable (Hakim and
Kelly 1989). An increased capillary pressure has been
shown in patients with PAH, also suggesting a high
venous resistance (Kafi et al. 1998). Recently Dorfmuller
et al. (2014) showed venous involvement in chronic
thromboembolic pulmonary hypertension. We therefore
suggest that rarefaction and increased venous resistance
should be studied in future research to determine their
role in hemodynamic changes.
Limitations
Although studying pulmonary pathology in human tissue
gives valuable insides, technical drawbacks are: Tissue
blocks used in this study were retrospectively selected
from the tissue biobank stored for diagnostic purposes.
We randomly selected tissue blocks from unknown loca-
tions, but it cannot be guaranteed to be representative for
the entire lung. That could also be true for the selection
of rounded, transversally cut vessels. Also, longitudinal
consistency of changes in the pulmonary vasculature has
not been shown and could add another dimension of
heterogeneity in vascular remodeling in PAH. Location of
Figure 3. Internal diameter (di) as a function of external diameter (do) as measured in five control subjects. Regression line is depicted with
black line.
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occlusive lesions in the pulmonary vasculature (proximal
vs. distal) could have a different impact on PVR. Studies
on three-dimensional vessel analyses and of the
pulmonary vasculature below 25 lm could improve
understanding of the relation between vascular remodel-
ing and PVR.
Figure 4. Internal diameter (di) as a function of external diameter (do) as measured in six PAH patients. Regression line, depicted with black
line, and the averaged control regression line (all control data of taken together, dotted line): di = 0.824 do + 0.260, R
2 = 0.993.
Figure 5. Log–log plots of the diameters of control (A) and PAH vessels. Diameters of control (A) and PAH (B) vessels per order (Strahler order
numbers indicated on top), both with the regression line (RL) and the lower 90% prediction line (PL) of the control data. The vertical lines
indicate the order limits. The PAH data points under the control PL are classified as narrowed vessels (red dots).
ª 2017 The Authors. Physiological Reports published by Wiley Periodicals, Inc. on behalf of
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Diameters have been determined using samples of
autopsy material where vessels are possibly (maximally)
vasodilated and are therefore not necessarily representa-
tive of the in vivo situation. The possibility of differences
in vasoactive state at death and potential differences of
changes in vasodilation/constriction during fixation are,
at present, not known. However, there is no reason to
assume differences regarding vasoconstriction and vasodi-
lation between the control and PAH vessels after fixation
and embedding.
Whether or not rarefaction of vessels exists could not
be determined. To assess this phenomenon, lengths and
diameters and the total number of vessels or total
endothelial surface area in control and PAH patients
should be measured and compared in various regions of
the lungs.
The presented data suggest that vascular remodeling
results in a relatively small increase in PVR, which is
insufficient to fully explain pulmonary vascular resistance
as observed in PAH patients. Absolute numbers of vessels,
wall thickness measurements of vessels below 25 lm, and
even information on the venous vasculature are required.
Conclusion
We show that structural changes in the pulmonary vascu-
lature of PAH patients are heterogeneous: 70% of vessels
are not altered and of the affected vasculature, the degree
of diameter decrease varies greatly. These diameter
changes alone cannot explain the resistance increase in
PAH.
Perspectives
It is generally assumed that in pulmonary arterial hyper-
tension (PAH), structural changes of the (small) pul-
monary arteries in combination with vasoconstriction are
Figure 6. Number and diameter fractions per order. (A) Number fractions Fn(m) as function of order. (B) Diameter fractions of the vessels Fd(m)
per order. The regression lines with their 95% confidence intervals are shown. The slope of Fn(m) is not significant (P = 0.70); the slope of Fd(m) is
significant (P < 0.0001). The circles on the upper and lower confidence limits indicate the values of Fn(m) and Fd(m) that predict the worst case
that a maximal number of vessels are involved with a minimal inner diameter, thereby contributing maximally to the resistance increase.
Figure 7. Contributors to increased pulmonary vascular resistance.
Increased pulmonary vascular resistance (PVR) can not only be
attributed to vasoconstriction and pulmonary vascular remodeling;
it is likely that increased venous resistance and rarefaction also
contribute to hemodynamic changes seen in pulmonary arterial
hypertension.
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the predominant cause of the increased resistance to
blood flow and high pressure. We show that structural
changes in the pulmonary arterial vasculature are hetero-
geneous: only 30–50% of the resistance arteries are nar-
rowed and narrowing varies in vessel orders and possibly
along vessel length. These changes cannot fully explain
the resistance increase in PAH. Future studies should
investigate increases in wall thickness of veins, wall thick-
ness differences along the length of resistance vessels, and
arterial/venous rarefaction to provide better estimates of
pulmonary vascular resistance.
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